Skip Navigation

U.S. regulators set to approve first CRISPR-based gene-editing treatment

Health and Science

U.S. regulators set to approve first CRISPR-based gene-editing treatment

01:36

Thu, Dec 7 20238:27 AM EST

Angelica Peebles

Patrick Manning

'The party is just getting started' for AI: Wedbush's Dan Ives following Nvidia's blowout earnings

'The party is just getting started' for AI: Wedbush's Dan Ives following Nvidia's blowout earnings

Language models 'just the beginning' of accelerated computing: Snowflake CEO on working with Nvidia

Language models 'just the beginning' of accelerated computing: Snowflake CEO on working with Nvidia

Nvidia stock hits all-time high after blowout quarter

Nvidia stock hits all-time high after blowout quarter

Chris Rolland weighs in on Nvidia's quarter as stock jumps on earnings and revenue beat

Chris Rolland weighs in on Nvidia's quarter as stock jumps on earnings and revenue beat

Nvidia beats on revenue and earnings, announces 10-for-1 stock split

Nvidia beats on revenue and earnings, announces 10-for-1 stock split

'The party is just getting started' for AI: Wedbush's Dan Ives following Nvidia's blowout earnings

'The party is just getting started' for AI: Wedbush's Dan Ives following Nvidia's blowout earnings

Language models 'just the beginning' of accelerated computing: Snowflake CEO on working with Nvidia

Language models 'just the beginning' of accelerated computing: Snowflake CEO on working with Nvidia

Nvidia stock hits all-time high after blowout quarter

Nvidia stock hits all-time high after blowout quarter

Chris Rolland weighs in on Nvidia's quarter as stock jumps on earnings and revenue beat

Chris Rolland weighs in on Nvidia's quarter as stock jumps on earnings and revenue beat

Nvidia beats on revenue and earnings, announces 10-for-1 stock split

Nvidia beats on revenue and earnings, announces 10-for-1 stock split